Company ............................. RedStorm Scientific is a computational biotechnology company utilizing a proprietary modeling platform to facilitate the design and optimization of protein pharmaceuticals. RedStorm’s novel technology (FyrestarTM) allows our pharmaceutical clients to efficiently generate and optimize compounds that have improved performance characteristics and therefore have an increased probability of withstanding the drug approval process. Protein pharmaceuticals, which include monoclonal antibodies, account for a growing proportion of both approved drugs and prospective drug candidates in the industry pipeline. Not surprisingly, they also account for a growing proportion of pharmaceutical research and development costs. As such, the rapid, cost-effective optimization of protein lead compounds is critical to future drug discovery. Due to their large size and complexity, however, protein pharmaceuticals pose unique challenges to effective design and development efforts. Specifically, the number of possible changes that can be made to a protein drug are of astronomic proportions, while the fraction of those changes that produce advantageous results is miniscule. As a result, exhaustive trial and error efforts, which are designed to identify improvements, are impossible, often leaving critical development decisions to guesswork. RedStorm’s platform technology can circumvent many of these computational problems, thereby removing the guesswork and providing rational, quantitatively-based solutions.

Company | Technology | Partnerships | Public Relations | Management | Jobs | Contact Us
Copyright Redstorm Scientific 2003